Page last updated: 2024-11-04

sulfadiazine and Nervous System Disorders

sulfadiazine has been researched along with Nervous System Disorders in 2 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Research Excerpts

ExcerptRelevanceReference
"Seventeen of 18 children without hydrocephalus and six of eight children with obstructive hydrocephalus responsive to shunting had normal or near-normal neurologic and developmental outcomes."1.29Neurologic and developmental outcome in treated congenital toxoplasmosis. ( Boyer, KM; Holfels, E; Hopkins, J; Meier, P; Mets, MB; Patel, D; Roizen, N; Stein, L; Stein, MA; Swisher, CN, 1995)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roizen, N1
Swisher, CN1
Stein, MA1
Hopkins, J1
Boyer, KM1
Holfels, E1
Mets, MB1
Stein, L1
Patel, D1
Meier, P1
Townsend, JJ1
Wolinsky, JS1
Baringer, JR1
Johnson, PC1

Other Studies

2 other studies available for sulfadiazine and Nervous System Disorders

ArticleYear
Neurologic and developmental outcome in treated congenital toxoplasmosis.
    Pediatrics, 1995, Volume: 95, Issue:1

    Topics: Child Development; Female; Humans; Hydrocephalus; Infant; Infant, Newborn; Intelligence; Longitudina

1995
Acquired toxoplasmosis. A neglected cause of treatable nervous system disease.
    Archives of neurology, 1975, Volume: 32, Issue:5

    Topics: Adult; Bronchopneumonia; Clinical Laboratory Techniques; Female; Fluorescent Antibody Technique; Hod

1975